This inventor holds 6 USPTO granted patents. Top assignee: Roussel Uclaf. Active years: 1976-1984.
Company Filing History:
Years Active: 1976-1984
Title: Michel Vignau: Innovator in Pharmaceutical Chemistry
Introduction
Michel Vignau is a notable inventor based in Neuilly-sur-Seine, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with antibacterial and antibiotic properties. With a total of 6 patents to his name, Vignau's work has had a considerable impact on medical science.
Latest Patents
Among his latest patents, Vignau has developed innovative oximes and cephalosporanic acids. His patent on oximes includes novel compounds that exhibit antibacterial activity, featuring complex chemical structures designed for pharmaceutical applications. Additionally, his work on 7-(2-amino-4-thiazolyl)-acetamido cephalosporanic acids presents new syn isomers that possess antibiotic properties, showcasing his expertise in creating effective medicinal compounds.
Career Highlights
Michel Vignau has had a distinguished career at Roussel Uclaf, a prominent pharmaceutical company. His research has focused on synthesizing compounds that can lead to advancements in antibiotic treatments. Vignau's innovative approach to drug development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Vignau has collaborated with esteemed colleagues such as Rene Heymes and Andre Lutz. These partnerships have fostered a collaborative environment that has enhanced the quality and scope of his research.
Conclusion
Michel Vignau's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medical treatments and drug development.